Translations:Biosimilar/21/en: Difference between revisions
Jump to navigation
Jump to search
Importing a new version from external source |
(No difference)
|
Latest revision as of 09:54, 20 March 2024
Nomenclature
In the European Union, no unique identifier of a biosimilar medicine product is required, as the same rules are followed as for all biologics.